Related references
Note: Only part of the references are listed.Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD)
George M. Solomon et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation
Philip M. Farrell et al.
JOURNAL OF PEDIATRICS (2017)
Potential New Agents for the Management of Hyperkalemia
David K. Packham et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2016)
Cystic fibrosis
Felix Ratjen et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Acute Hyperkalemia Associated with Inhalation of a Potent ENaC Antagonist: Phase 1 Trial of GS-9411
Thomas G. O'Riordan et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2014)
Novel small molecule epithelial sodium channel inhibitors as potential therapeutics in cystic fibrosis - a patent evaluation
Matthias Schoenberger et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Multisite Comparison of Mucociliary and Cough Clearance Measures Using Standardized Methods
William D. Bennett et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2013)
ENaC Inhibitors and Airway Re-hydration in Cystic Fibrosis: State of the Art
Mike Althaus
Current Molecular Pharmacology (2013)
Assessment of the CFTR and ENaC association
Bakhrom K. Berdiev et al.
MOLECULAR BIOSYSTEMS (2009)
Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report
Philip M. Farrell et al.
JOURNAL OF PEDIATRICS (2008)
Evidence for airway surface dehydration as the initiating event in CF airway disease
R. C. Boucher
JOURNAL OF INTERNAL MEDICINE (2007)
Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease
AJ Hirsh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Share Paper
